Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus
Status:
Withdrawn
Trial end date:
2018-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of alogliptin tablets when
given as monotherapy or add on therapy in participants who are on standard care for
management of Type 2 Diabetes Mellitus (T2DM).